14-03-2025 17:13 via medpagetoday.com

Approved Sickle Cell Drug Fails to Beat Placebo in Trial

(MedPage Today) -- Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
Adjusted annualized rate of vaso-occlusive crises leading to healthcare visits was 2.49 with the standard...
Read more »

Medical news



Proteinuria Linked to Sudden Cardiac Arrest in Young Adults
Paradoxical PSA Association With Mortality After Radical Prostatectomy
Dr. Oz Gets Generally Good Reception in Confirmation Hearing for CMS Administrator
Measles Cases Reach 294 in Texas and New Mexico: Here's What to Know
Clonidine Reduced Blood Loss, Transfusions in Pelvic/Acetabular Fracture Surgery
RFK Jr. Falsely Claims Measles Vax Causes Deaths 'Every Year'
High Price of GLP-1 Agents Tip Cost-Benefit Scale Unfavorably
New-Onset Seasonal Allergies in Adults
The Risks of Universal Water Fluoridation and 'No Known Harm'
Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing
Scrubs, Sweat, and Solidarity: Making Friends in Residency
Longtime Congressman Dies; Acne Creams Recalled; Did Dr. Oz Avoid Medicare Taxes?
Public Health Groups Not Shedding Tears Over Weldon's Failed CDC Bid
MedPAC Report Calls for Increases in Doc Pay for Medicare Services
Desktop versie